News
-
-
-
PRESS RELEASE
SGL Carbon: Business development in 2024 in line with guidance. Weaker momentum in sales markets expected for 2025
SGL Carbon's 2024 business development met guidance, but 2025 faces weaker sales momentum. Focus on restructuring Carbon Fibers unit and new sales opportunities amidst subdued demand -
-
-
-
PRESS RELEASE
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio, for upfront amount of USD 600 million, plus potential milestones
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio for $600 million upfront plus potential milestones, enhancing HBM Healthcare Investments -
-
-